Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: jm2i123 who wrote (11940)	5/15/2013 3:39:34 PM
From: NTTG	2 Recommendations Read Replies (2) \| Respond to of 13111

I had prostate cancer, 3 years of zero PSA since surgery, thanks for asking. Have not made fun of cancer patients (strike 1) Have never been kicked out of a lab (strike 2) My comment was that investors would not see a return on investment (Strike 3) and the company would run out of cash as soon as they tried to start a PIII trial if they did not come up with another funding source. MGT continues to dilute investor value with private placements (to the end of 2013 now), final outcome of the cash to product race is still to be determined. Why would he be desperate for my call; I know why, but doesn't that seem ironic to you? Never claimed that DNDN was a well run company (strike 4), but I did appreciate the science of their molecule and the fact that they got to market....how is PVCT doing along that line? LMAO, I never claimed to be an advisor for the FDA (strike 5), perhaps you should think about dialing back some medication dosages, these hallucinogenic side effects of yours are really getting bad